Submission Details
| 510(k) Number | K241390 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 15, 2024 |
| Decision Date | November 26, 2024 |
| Days to Decision | 195 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K241390 is an FDA 510(k) clearance for the NeuroMatch, a Automatic Event Detection Software For Full-montage Electroencephalograph (Class II — Special Controls, product code OMB), submitted by LVIS Corporation (Palo Alto, US). The FDA issued a Cleared decision on November 26, 2024, 195 days after receiving the submission on May 15, 2024. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1400.
| 510(k) Number | K241390 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 15, 2024 |
| Decision Date | November 26, 2024 |
| Days to Decision | 195 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | OMB — Automatic Event Detection Software For Full-montage Electroencephalograph |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1400 |
| Definition | Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User |